Comparison of the characteristics of patients with either ST-segment elevation myocardial infarction or non-ST-segment elevation myocardial infarction enrolled in the Elderly ACS 2 trial2
| . | STEMI (n = 595) . | NSTEACS (n = 848) . | P . |
|---|---|---|---|
| Diabetes | 151 (25.4) | 269 (31.7) | 0.009 |
| Hypertension | 426 (71.6) | 694 (81.8) | <0.001 |
| Hypercholesterolaemia | 228 (38.3) | 416 (49.1) | <0.001 |
| Smoking | 63 (10.6) | 68 (8.0) | 0.094 |
| Chronic obstructive pulmonary disease | 23 (3.9) | 64 (7.5) | 0.004 |
| eGFRa at admission (mL/min/1.73 m2) | 55 (43–67) | 55 (42–68) | 0.781 |
| Previous cardiovascular events | |||
| Myocardial infarction | 52 (8.7) | 222 (26.2) | <0.001 |
| Coronary angioplasty | 62 (10.4) | 202 (23.8) | <0.001 |
| Coronary artery bypass | 22 (3.7) | 106 (12.5) | <0.001 |
| Peripheral arterial disease | 36 (6.1) | 89 (10.5) | 0.003 |
| Left ventricular ejection fraction | 45 (40–55) | 50 (45–55) | <0.001 |
| Three-vessel coronary disease | 141 (23.8) | 291 (34.4) | |
| Left main disease | 16 (2.7) | 83 (9.8) | <0.001 |
| . | STEMI (n = 595) . | NSTEACS (n = 848) . | P . |
|---|---|---|---|
| Diabetes | 151 (25.4) | 269 (31.7) | 0.009 |
| Hypertension | 426 (71.6) | 694 (81.8) | <0.001 |
| Hypercholesterolaemia | 228 (38.3) | 416 (49.1) | <0.001 |
| Smoking | 63 (10.6) | 68 (8.0) | 0.094 |
| Chronic obstructive pulmonary disease | 23 (3.9) | 64 (7.5) | 0.004 |
| eGFRa at admission (mL/min/1.73 m2) | 55 (43–67) | 55 (42–68) | 0.781 |
| Previous cardiovascular events | |||
| Myocardial infarction | 52 (8.7) | 222 (26.2) | <0.001 |
| Coronary angioplasty | 62 (10.4) | 202 (23.8) | <0.001 |
| Coronary artery bypass | 22 (3.7) | 106 (12.5) | <0.001 |
| Peripheral arterial disease | 36 (6.1) | 89 (10.5) | 0.003 |
| Left ventricular ejection fraction | 45 (40–55) | 50 (45–55) | <0.001 |
| Three-vessel coronary disease | 141 (23.8) | 291 (34.4) | |
| Left main disease | 16 (2.7) | 83 (9.8) | <0.001 |
aeGFR, estimated glomerular filtration rate (Cockroft–Gault formula).
Comparison of the characteristics of patients with either ST-segment elevation myocardial infarction or non-ST-segment elevation myocardial infarction enrolled in the Elderly ACS 2 trial2
| . | STEMI (n = 595) . | NSTEACS (n = 848) . | P . |
|---|---|---|---|
| Diabetes | 151 (25.4) | 269 (31.7) | 0.009 |
| Hypertension | 426 (71.6) | 694 (81.8) | <0.001 |
| Hypercholesterolaemia | 228 (38.3) | 416 (49.1) | <0.001 |
| Smoking | 63 (10.6) | 68 (8.0) | 0.094 |
| Chronic obstructive pulmonary disease | 23 (3.9) | 64 (7.5) | 0.004 |
| eGFRa at admission (mL/min/1.73 m2) | 55 (43–67) | 55 (42–68) | 0.781 |
| Previous cardiovascular events | |||
| Myocardial infarction | 52 (8.7) | 222 (26.2) | <0.001 |
| Coronary angioplasty | 62 (10.4) | 202 (23.8) | <0.001 |
| Coronary artery bypass | 22 (3.7) | 106 (12.5) | <0.001 |
| Peripheral arterial disease | 36 (6.1) | 89 (10.5) | 0.003 |
| Left ventricular ejection fraction | 45 (40–55) | 50 (45–55) | <0.001 |
| Three-vessel coronary disease | 141 (23.8) | 291 (34.4) | |
| Left main disease | 16 (2.7) | 83 (9.8) | <0.001 |
| . | STEMI (n = 595) . | NSTEACS (n = 848) . | P . |
|---|---|---|---|
| Diabetes | 151 (25.4) | 269 (31.7) | 0.009 |
| Hypertension | 426 (71.6) | 694 (81.8) | <0.001 |
| Hypercholesterolaemia | 228 (38.3) | 416 (49.1) | <0.001 |
| Smoking | 63 (10.6) | 68 (8.0) | 0.094 |
| Chronic obstructive pulmonary disease | 23 (3.9) | 64 (7.5) | 0.004 |
| eGFRa at admission (mL/min/1.73 m2) | 55 (43–67) | 55 (42–68) | 0.781 |
| Previous cardiovascular events | |||
| Myocardial infarction | 52 (8.7) | 222 (26.2) | <0.001 |
| Coronary angioplasty | 62 (10.4) | 202 (23.8) | <0.001 |
| Coronary artery bypass | 22 (3.7) | 106 (12.5) | <0.001 |
| Peripheral arterial disease | 36 (6.1) | 89 (10.5) | 0.003 |
| Left ventricular ejection fraction | 45 (40–55) | 50 (45–55) | <0.001 |
| Three-vessel coronary disease | 141 (23.8) | 291 (34.4) | |
| Left main disease | 16 (2.7) | 83 (9.8) | <0.001 |
aeGFR, estimated glomerular filtration rate (Cockroft–Gault formula).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
